JP2024516826A5 - - Google Patents
Info
- Publication number
- JP2024516826A5 JP2024516826A5 JP2023566480A JP2023566480A JP2024516826A5 JP 2024516826 A5 JP2024516826 A5 JP 2024516826A5 JP 2023566480 A JP2023566480 A JP 2023566480A JP 2023566480 A JP2023566480 A JP 2023566480A JP 2024516826 A5 JP2024516826 A5 JP 2024516826A5
- Authority
- JP
- Japan
- Prior art keywords
- oxazepan
- carboxamide
- ethyl
- cyano
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181817P | 2021-04-29 | 2021-04-29 | |
| US63/181,817 | 2021-04-29 | ||
| PCT/US2022/027026 WO2022232573A1 (en) | 2021-04-29 | 2022-04-29 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating cystic fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024516826A JP2024516826A (ja) | 2024-04-17 |
| JP2024516826A5 true JP2024516826A5 (https=) | 2025-05-09 |
Family
ID=83848696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023566480A Pending JP2024516826A (ja) | 2021-04-29 | 2022-04-29 | 嚢胞性線維症を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240226112A1 (https=) |
| EP (1) | EP4329767A4 (https=) |
| JP (1) | JP2024516826A (https=) |
| KR (1) | KR20240004691A (https=) |
| CA (1) | CA3215375A1 (https=) |
| WO (1) | WO2022232573A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) | 2014-01-24 | 2018-02-24 | ||
| HUE070049T2 (hu) | 2018-03-01 | 2025-05-28 | Astrazeneca Ab | (2S)-{(1S)-1-ciano-2-[4-(3-metil-2-oxo-2,3-dihidro-1,3-benzoxazol-5-il)fenil]etil} -1,4-oxazepán-2-karboxamidot tartalmazó gyógyászati készítmények |
| WO2020018547A1 (en) | 2018-07-17 | 2020-01-23 | Insmed Incorporated | Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis |
| JP2026503035A (ja) * | 2023-01-06 | 2026-01-27 | インスメッド インコーポレイテッド | 新規な可逆性ｄｐｐ１阻害剤及びその用途 |
| JP2026510407A (ja) * | 2023-03-23 | 2026-04-02 | ハイスコ ファーマスーティカル プライベート リミテッド | ジペプチジルペプチダーゼ小分子阻害剤を含む医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004076434A1 (en) * | 2003-02-28 | 2004-09-10 | Aic | Dipeptidyl peptidase inhibitors |
| ES2845473T3 (es) * | 2013-03-14 | 2021-07-26 | Boehringer Ingelheim Int | (Bencil-ciano-metil)-amidas sustituidas de ácido 2-aza-biciclo[2.2.1]heptano-3-carboxílico inhibidores de la catepsina- C |
| NO2699580T3 (https=) * | 2014-01-24 | 2018-02-24 | ||
| JP6783426B2 (ja) * | 2015-03-05 | 2020-11-11 | ニュープロザイム・セラピューティクス・アンパルトセルスカブＮｅｕｐｒｏｚｙｍｅ Ｔｈｅｒａｐｅｕｔｉｃｓ ＡｐＳ | ジペプチジルペプチダーゼｉ阻害剤としてのペプチジルニトリル化合物 |
| KR20240091302A (ko) * | 2016-07-29 | 2024-06-21 | 인스메드 인코포레이티드 | 기관지확장증을 치료하기 위한 특정 (2s)-n-[(1s)-1-시아노-2-페닐에틸]-1,4-옥사제판-2-카르복스아미드 |
| HUE070049T2 (hu) * | 2018-03-01 | 2025-05-28 | Astrazeneca Ab | (2S)-{(1S)-1-ciano-2-[4-(3-metil-2-oxo-2,3-dihidro-1,3-benzoxazol-5-il)fenil]etil} -1,4-oxazepán-2-karboxamidot tartalmazó gyógyászati készítmények |
-
2022
- 2022-04-29 US US18/288,338 patent/US20240226112A1/en active Pending
- 2022-04-29 KR KR1020237040988A patent/KR20240004691A/ko active Pending
- 2022-04-29 EP EP22796849.2A patent/EP4329767A4/en not_active Withdrawn
- 2022-04-29 JP JP2023566480A patent/JP2024516826A/ja active Pending
- 2022-04-29 WO PCT/US2022/027026 patent/WO2022232573A1/en not_active Ceased
- 2022-04-29 CA CA3215375A patent/CA3215375A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024516826A5 (https=) | ||
| JP2023156479A5 (https=) | ||
| JP2022096662A5 (https=) | ||
| JP2019038820A5 (https=) | ||
| JP2021530513A5 (https=) | ||
| JP2021512904A5 (https=) | ||
| JP2019077725A5 (https=) | ||
| JP2023504415A5 (https=) | ||
| JP2024540445A5 (https=) | ||
| JP2009531280A5 (https=) | ||
| RU2011153772A (ru) | Фторированные аминотриазольные производные | |
| JP2022552655A5 (https=) | ||
| JP2025508359A5 (https=) | ||
| JP2021530525A5 (https=) | ||
| JP2015145408A (ja) | 非定型抗精神病薬及びｔａａｒ１アゴニストを含む組合せ | |
| JP2024540142A5 (https=) | ||
| JP2022542140A5 (https=) | ||
| JP2025512098A5 (https=) | ||
| JP2018203774A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| JP2010519278A5 (https=) | ||
| JP2005508363A5 (https=) | ||
| RU2009135255A (ru) | Производные индола | |
| CA2708418A1 (en) | Oxazolidinones for the treatment and/or prophylaxis of heart failure | |
| JP2025505609A5 (https=) | ||
| JP2022541311A5 (https=) |